Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:1458-1466
Published online before print February 26, 2009, doi: 10.1161/STROKEAHA.108.535930
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/4/1458    most recent
STROKEAHA.108.535930v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuhlmann, C. R.W.
Right arrow Articles by Luhmann, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuhlmann, C. R.W.
Right arrow Articles by Luhmann, H. J.
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Endothelium/vascular type/nitric oxide

(Stroke. 2009;40:1458.)
© 2009 American Heart Association, Inc.


Original Contributions

Mechanisms of C-Reactive Protein-Induced Blood–Brain Barrier Disruption

Christoph R.W. Kuhlmann, MD; Laura Librizzi, PhD; Dorothea Closhen, MD; Thorsten Pflanzner; Volkmar Lessmann, PhD; Claus U. Pietrzik, PhD; Marco de Curtis, MD Heiko J. Luhmann, PhD

From the Institute of Physiology and Pathophysiology (C.R.W.K., D.C., V.L., H.J.L.), Johannes Gutenberg University of Mainz, Mainz, Germany; the Department of Experimental Neurophysiology (L.L., M.d.C.), Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta via Celoria 11, Milan, Italy; the Institute for Physiological Chemistry and Pathobiochemistry (T.P., C.U.P.), Johannes Gutenberg University of Mainz, Mainz, Germany; and the Institute for Physiology (V.L.), Otto-von-Guericke University, Magdeburg, Germany.

Correspondence to Heiko J. Luhmann, PhD, Johannes Gutenberg University of Mainz, Institute of Physiology and Pathophysiology, Duesbergweg 6, 55128 Mainz, Germany. E-mail luhmann{at}uni-mainz.de

Background and Purpose— Increased mortality after stroke is associated with brain edema formation and high plasma levels of the acute phase reactant C-reactive protein (CRP). The aim of this study was to examine whether CRP directly affects blood–brain barrier stability and to analyze the underlying signaling pathways.

Methods— We used a cell coculture model of the blood–brain barrier and the guinea pig isolated whole brain preparation.

Results— We could show that CRP at clinically relevant concentrations (10 to 20 µg/mL) causes a disruption of the blood–brain barrier in both approaches. The results of our study further demonstrate CRP-induced activation of surface Fc{gamma} receptors CD16/32 followed by p38-mitogen-activated protein kinase-dependent reactive oxygen species formation by the NAD(P)H-oxidase. The resulting oxidative stress increased myosin light chain kinase activity leading to an activation of the contractile machinery. Blocking myosin light chain phosphorylation prevented the CRP-induced blood–brain barrier breakdown and the disruption of tight junctions.

Conclusions— Our data identify a previously unrecognized mechanism linking CRP and brain edema formation and present a signaling pathway that offers new sites of therapeutic intervention.

Supplemental Methods